Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Medical Management of Meningiomas: Current Status, Failed Treatments, and Promising Horizons.

Neurosurgery clinics of North America - 1 Apr 2016

Karsy Michael, Guan Jian, Cohen Adam, Colman Howard, Jensen Randy L

Abstract excerpt

Meningiomas are benign tumors of the central nervous system, with low recurrence risk for World Health Organization (WHO) grade I lesions but a high risk for WHO grade II and III lesions. Current standard treatments include maximum safe surgical resection when indicated and radiation. Only three systemic therapies alpha-interferon, somatostatin receptor agonists, and vascular endothelial growth factor inhibitors...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Combined Modality Therapy
Share to Hydroxyurea

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Meningeal Neoplasms

Share to Meningioma

Share to Neovascularization, Pathologic

Share to Receptor Protein-Tyrosine Kinases

Share to Somatostatin

Share to Treatment Failure

Source

Identifiers

PMID: 27012389
DOI: 10.1016/j.nec.2015.11.002

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Medical Management of Meningiomas: Current Status, Failed Treatments, and Promising Horizons.PMID 27012389Read ↗

Current treatment options for meningioma.Semantic proximity Read ↗

Recent advances in managing/understanding meningiomaSemantic proximity Read ↗

Innovative treatments for meningiomas.Semantic proximity Read ↗

Medical management of meningioma in the era of precision medicine.Semantic proximity Read ↗

A Review of Recurrent Meningiomas with Prolonged Response to Cabozantinib, an Oral Multitarget Tyrosine Kinase InhibitorSemantic proximity Read ↗

Clinical potential of meningioma genomic insights: a practical review for neurosurgeons.Semantic proximity Read ↗

European Association of Neuro-Oncology guideline on molecular testing of meningiomas for targeted therapy selectionSemantic proximity Read ↗

Gene therapy and nanomedicine for meningioma treatmentSemantic proximity Read ↗

[The Potential of Personalized/Precision Medicine for Meningiomas].Semantic proximity Read ↗

A Review of Recurrent Meningiomas with Prolonged Response to Cabozantinib, an Oral Multitarget Tyrosine Kinase InhibitorSemantic proximity Read ↗

Evolving concepts in meningioma management in the era of genomicsSemantic proximity Read ↗

[Intracranial meningiomas: I. Epidemiology, aetiology, pathogenesis and prognostic factors].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.